A 42-year-old man undergoes elective right inguinal hernia repair under spinal anesthesia with 3 mL of 0.5% bupivacaine. Thirty minutes into the procedure, the patient develops sudden onset tinnitus, circumoral numbness, and restlessness. His blood pressure is 165/95 mmHg, heart rate 118/min, and oxygen saturation 98% on room air. Within 2 minutes, he becomes confused and has a brief generalized tonic-clonic seizure. What is the most appropriate immediate management?

Explanation

## Clinical Diagnosis: Local Anesthetic Systemic Toxicity (LAST) ### Mechanism of Toxicity **Key Point:** Bupivacaine is a long-acting amide local anesthetic with high cardiotoxicity. Accidental intravascular injection or overdose causes rapid CNS and cardiac toxicity. ### Timeline of LAST Manifestations 1. **Early CNS signs (0–5 min):** Tinnitus, circumoral numbness, restlessness, tremor 2. **Seizure phase:** Generalized tonic-clonic seizure (as in this case) 3. **Late phase:** Loss of consciousness, apnea, cardiovascular collapse ### Management Algorithm ```mermaid flowchart TD A[Suspected LAST]:::outcome --> B[Stop injection immediately]:::action B --> C[Call for help & lipid emulsion]:::action C --> D[Secure airway & 100% O2]:::action D --> E[Seizure control]:::action E --> F[20% Lipid emulsion<br/>1.5 mL/kg IV bolus]:::action F --> G[Infusion 0.25 mL/kg/min]:::action G --> H{Cardiovascular stability?}:::decision H -->|Unstable| I[Repeat bolus q5min<br/>Max 10-12 mL/kg first 1 hr]:::action H -->|Stable| J[Continue infusion<br/>Monitor 4-6 hours]:::action I --> K[Consider ECMO if<br/>refractory arrest]:::urgent ``` ### Lipid Emulsion Therapy: Dosing & Evidence | Parameter | Value | |-----------|-------| | **Initial bolus** | 1.5 mL/kg (20% lipid) IV over 1 min | | **Infusion rate** | 0.25 mL/kg/min | | **Repeat bolus** | Every 5–10 min if unstable (max 2 boluses) | | **Max cumulative dose** | 10–12 mL/kg in first hour | | **Mechanism** | Lipophilic sequestration of bupivacaine in plasma; reverses CNS & cardiac toxicity | **High-Yield:** Lipid emulsion is now the **gold standard** for LAST management. It has dramatically improved outcomes compared to supportive care alone [cite:Anesth Analg 2010]. ### Why Lipid Emulsion Works - Bupivacaine is highly lipophilic (pKa 8.1, protein binding 95%) - Lipid phase sequesters the drug away from cardiac and neuronal tissue - Restores cardiac contractility and cerebral perfusion **Clinical Pearl:** Even if the patient appears to recover after seizure, **continue lipid infusion for 4–6 hours** because delayed cardiovascular collapse can occur. ### Supportive Measures (Concurrent) - Secure airway; intubate if seizure or apnea - 100% oxygen (hyperoxia improves lipid solubility) - Seizure control: succinylcholine or rocuronium (NOT propofol — lipophilic, competes with lipid) - Avoid vasopressin, calcium channel blockers, propofol, and local anesthetics - If cardiac arrest: prolonged CPR (>1 hour may be needed); consider ECMO if refractory